Treatment of Recurrent Intraocular Melanoma

The prognosis for any patient with recurring or relapsing disease is poor, regardless of cell type or stage. The question and selection of further treatment depends on many factors, including the extent of the lesion, age and health of the patient, prior treatment, site of recurrence, and individual patient considerations. Surgical resection of metastases diagnosed after initial management of ocular melanoma in single-center case series of highly selected patients has been reported. The extent to which the occasional favorable outcomes are the result of strong selection factors is not clear, so this approach cannot be considered standard.[1]

Eligible patients should consider participation in clinical trials whenever possible.